Changes of Heart Structure and Function in Terms of Insulin Resistance at Thyrotoxicosis Syndrome
The article presents the findings of the study on the effect of increased thyroid function on the background of insulin resistance on the performance of the structure and function of the heart. It has been found that in increased thyroid function, main nosological form of myocardial damage in patients without concomitant cardiovascular disease is the development of metabolic endocrine cardiomyopathy. Feature of heart disorder in thyrotoxicosis syndrome is an absence of cardosclerotic, myocarditic and ischemic processes. Features of clinical, instrumental and laboratory changes in patients with elevated thyroid function are subjective manifestation, trend towards the development of systolic hypertension, expressed hypolipidemia, tendency to hyperglycemia. Manifestations of electrical dysfunction of the myocardium in hyperthyroidism are increased heart rate, expressed trend towards increase of arrhythmogenesis (mainly ventricular type), disturbance of ventricular repolarization and the prevalence of electrical inhomogeneity of the myocardium of both atria and ventricles. Morphofunctional changes of the heart in thyrotoxicosis syndrome manifest by increase in the size of its cavities, left ventricular mass, rapid relaxation of the latter. Heart disease in thyrotoxicosis is characterized by an increase in the duration and dispersion of QTc interval, which indicates a violation of myocardial repolarization, and increase in its electrical inhomogeneity, which can be a predictor of the risk of ventricular arrhythmias. Changes in cardiac function at thyrotoxicosis in male patients are characterized by greater severity of electrophysiological and morphofunctional changes in the myocardium compared to female patients.
Full Text:PDF (Українська)
Балаболкин М.И., Клебанова Е.М., Креминская В.М. Фундаментальная и клиническая тиреоидология: Руководство. — М.: Медицина, 2007. — 816 с.
Карась А.С. Щитовидная железа и сердце / Карась А.С., Обрезан А.Г. // Клиническая и экспериментальная тиреоидология. — 2009. — № 3. — С. 37-42.
Паньків В.І. Практична тиреоїдологія. — Донецьк, 2011. — 224 c.
Brenta G. Diabetes and thyroid disorders // British Journal of Diabetes and Vascular Disease. — 2010. — Vol. 10(4). — P. 172-177.
Cappola A.R., Fried L.P., Arnold A.M. et al. Thyroid status, cardiovascular risk, and mortality in older adults // JAMA. — 2006 — Vol. 295, № 9. — P. 1033-1041.
Flynn R.W., McDonald T.M., Jung R.T. et al. Mortality and vascular outcomes in patients treated for thyroid dysfunction // J. Clin. Endocrinol. Metab. — 2006. — Vol. 91, № 6. — P. 2159-2164.
Rezzonico J., Niepomniszcze H., Rezzonico M. et al. The association of insulin resistance with subclinical thyrotoxicosis // Thyroid. — 2011. — Vol. 21, № 9. — P. 945-949.
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.
© "Publishing House "Zaslavsky", 1997-2017